Another type is the small molecule multi‐target tyrosine kinase inhibitors, represented by drugs such as anlotinib and apatinib, which mainly acts on VEGF‐VEGFR signaling pathway and inhibition of the tumor neovascularization. This evidence concerns the gene KDR and neoplasm.